Presentation: “The Methodological Issues in Clinical Trials of Alzheimer’s Disease”

Amir Kalali, MD, Vice President and CNS Therapeutic Leader, Quintiles examines the issues faced in the design and conduct of Alzheimer’s clinical trials and explores what Alzheimer’s drug development will look like going forward. As presented at the International Conference on Alzheimer’s Disease (ICAD) in Paris, France on July 19, 2011.